vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $35.3M, roughly 1.4× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -4.8%, a 48.6% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $44.3M). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.

IRWD vs UNTY — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.4× larger
IRWD
$47.7M
$35.3M
UNTY
Growing faster (revenue YoY)
UNTY
UNTY
+71.5% gap
UNTY
24.2%
-47.3%
IRWD
Higher net margin
UNTY
UNTY
48.6% more per $
UNTY
43.9%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$30.2M more FCF
IRWD
$74.6M
$44.3M
UNTY
Faster 2-yr revenue CAGR
UNTY
UNTY
Annualised
UNTY
17.5%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
UNTY
UNTY
Revenue
$47.7M
$35.3M
Net Profit
$-2.3M
$15.5M
Gross Margin
Operating Margin
14.3%
55.8%
Net Margin
-4.8%
43.9%
Revenue YoY
-47.3%
24.2%
Net Profit YoY
-200.9%
34.5%
EPS (diluted)
$0.01
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
UNTY
UNTY
Q4 25
$47.7M
$35.3M
Q3 25
$122.1M
$32.8M
Q2 25
$85.2M
$34.4M
Q1 25
$41.1M
$29.4M
Q4 24
$90.5M
$28.4M
Q3 24
$91.6M
$27.7M
Q2 24
$94.4M
$25.5M
Q1 24
$74.9M
$25.6M
Net Profit
IRWD
IRWD
UNTY
UNTY
Q4 25
$-2.3M
$15.5M
Q3 25
$40.1M
$14.4M
Q2 25
$23.6M
$16.5M
Q1 25
$-37.4M
$11.6M
Q4 24
$2.3M
$11.5M
Q3 24
$3.6M
$10.9M
Q2 24
$-860.0K
$9.5M
Q1 24
$-4.2M
$9.6M
Operating Margin
IRWD
IRWD
UNTY
UNTY
Q4 25
14.3%
55.8%
Q3 25
61.8%
57.5%
Q2 25
53.2%
62.6%
Q1 25
-70.7%
52.6%
Q4 24
34.8%
51.0%
Q3 24
28.0%
52.7%
Q2 24
26.5%
49.3%
Q1 24
14.7%
50.0%
Net Margin
IRWD
IRWD
UNTY
UNTY
Q4 25
-4.8%
43.9%
Q3 25
32.8%
43.8%
Q2 25
27.7%
48.0%
Q1 25
-90.9%
39.5%
Q4 24
2.5%
40.5%
Q3 24
4.0%
39.4%
Q2 24
-0.9%
37.1%
Q1 24
-5.6%
37.5%
EPS (diluted)
IRWD
IRWD
UNTY
UNTY
Q4 25
$0.01
$1.52
Q3 25
$0.23
$1.41
Q2 25
$0.14
$1.61
Q1 25
$-0.23
$1.13
Q4 24
$0.03
$1.13
Q3 24
$0.02
$1.07
Q2 24
$-0.01
$0.92
Q1 24
$-0.03
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
UNTY
UNTY
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-261.8M
$345.6M
Total Assets
$396.9M
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
UNTY
UNTY
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
IRWD
IRWD
UNTY
UNTY
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
$230.8M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
IRWD
IRWD
UNTY
UNTY
Q4 25
$-261.8M
$345.6M
Q3 25
$-264.2M
$334.0M
Q2 25
$-308.2M
$319.8M
Q1 25
$-334.1M
$306.1M
Q4 24
$-301.3M
$295.6M
Q3 24
$-311.3M
$284.3M
Q2 24
$-321.7M
$273.4M
Q1 24
$-330.5M
$266.8M
Total Assets
IRWD
IRWD
UNTY
UNTY
Q4 25
$396.9M
$3.0B
Q3 25
$396.1M
$2.9B
Q2 25
$342.9M
$2.9B
Q1 25
$327.2M
$2.8B
Q4 24
$350.9M
$2.7B
Q3 24
$389.5M
$2.6B
Q2 24
$395.6M
$2.6B
Q1 24
$438.8M
$2.6B
Debt / Equity
IRWD
IRWD
UNTY
UNTY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
UNTY
UNTY
Operating Cash FlowLast quarter
$74.6M
$44.9M
Free Cash FlowOCF − Capex
$74.6M
$44.3M
FCF MarginFCF / Revenue
156.3%
125.7%
Capex IntensityCapex / Revenue
0.0%
1.6%
Cash ConversionOCF / Net Profit
2.90×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$81.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
UNTY
UNTY
Q4 25
$74.6M
$44.9M
Q3 25
$47.6M
$45.5M
Q2 25
$-15.1M
$-25.3M
Q1 25
$20.0M
$17.9M
Q4 24
$15.2M
$48.0M
Q3 24
$9.9M
$17.7M
Q2 24
$33.5M
$-8.4M
Q1 24
$45.0M
$15.8M
Free Cash Flow
IRWD
IRWD
UNTY
UNTY
Q4 25
$74.6M
$44.3M
Q3 25
$47.6M
$45.3M
Q2 25
$-15.1M
$-25.5M
Q1 25
$19.9M
$17.6M
Q4 24
$47.3M
Q3 24
$9.9M
$17.5M
Q2 24
$33.4M
$-8.6M
Q1 24
$44.9M
$15.7M
FCF Margin
IRWD
IRWD
UNTY
UNTY
Q4 25
156.3%
125.7%
Q3 25
39.0%
138.1%
Q2 25
-17.7%
-74.2%
Q1 25
48.4%
59.9%
Q4 24
166.5%
Q3 24
10.8%
63.3%
Q2 24
35.4%
-33.7%
Q1 24
60.0%
61.4%
Capex Intensity
IRWD
IRWD
UNTY
UNTY
Q4 25
0.0%
1.6%
Q3 25
0.0%
0.7%
Q2 25
0.0%
0.5%
Q1 25
0.1%
1.0%
Q4 24
0.0%
2.4%
Q3 24
0.0%
0.5%
Q2 24
0.1%
0.5%
Q1 24
0.1%
0.3%
Cash Conversion
IRWD
IRWD
UNTY
UNTY
Q4 25
2.90×
Q3 25
1.19×
3.16×
Q2 25
-0.64×
-1.54×
Q1 25
1.54×
Q4 24
6.74×
4.17×
Q3 24
2.71×
1.62×
Q2 24
-0.89×
Q1 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons